Premature coronary heart disease: The influence of positive family history on platelet activity in vivo in children and adolescents (family study)

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 4, Issue 1, 1997, Pages 13-18

  Akimova, Elena V ^a   Bogmat, Liudmila F ^a  

^a Ukrainian Research Institute of Forestry and Forest Melioratio   (Ukraine)

Author keywords

adolescents; children; coronary heart disease; heredity; platelets

Indexed keywords

BETA THROMBOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEART INFARCTION; HEREDITY; HUMAN; HYPERCOAGULABILITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADOLESCENT; ADULT; BETA-THROMBOGLOBULIN; CASE-CONTROL STUDIES; CHILD; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PLATELET ACTIVATION; RISK FACTORS; TIME FACTORS;

EID: 0030748353     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679700400103     Document Type: Article

References (30)

1. Ross R, Glomset JA: The pathogenesis of atherosclerosis N Engl J Med 1976, 295: 369–377, 420–425.
2. Badimon JJ, Fuster V, Chesebro JH, Badimon L: Coronary atherosclerosis. A multifactorial disease Circulation 1993, 87 (suppl 3):3–16.
3. Fuster V, Chesebro JH, Frye RL, Elveback LR: Platelet survival and the development of coronary artery disease in the young adults: Effects of cigarette smoking, strong family history, and medical therapy Circulation 1981, 63: 546–551.
4. Rabbini LE, Lascalzo J: Recent observations on the role of haemostatic determinants in the development of atherosclerotic plaque Atherosclerosis 1994, 105: 1–7.
5. Stary HC: Evolution of atherosclerosis plaques in the coronary arteries of young adults [abstract] Arteriosclerosis 1983, 3: 471a.
6. Stary HC: Evolution and progression of atherosclerotic lesions in coronary arteries in children and young adults Atherosclerosis 1989, 99 (suppl 1):119–132.
7. Ross R: The pathogenesis of atherosclerosis - an update N Engl J Med 1986, 314: 488–500.
8. De Carvallo S: Atherosclerosis. I. Leyomyoproliferative disease of the arteries resulting from breakdown of endothelial barrier to protein blood growth factors. II Perspectives in the prophylaxis Angiology 1985, 36: 697–710.
9. McCluer JV, Kammerer CM: Dissecting the genetic contribution to coronary heart disease Am J Hum Genet 1991, 49: 1139–1144.
10. Fridlander Y, Kark JD, Stein Y: Family history of myocardial infarction as an independent risk factor for coronary heart disease Br Heart J 1985, 53: 382–387.
11. Ludlam CA: Evidence for platelet specificity of beta-thromboglobulin and studies of its plasma concentration in healthy individuals Br J Haematol 1979, 41: 271–278.
12. Kaplan KL, Owen J: Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981, 57: 191–202.
13. Ferstrate M, Vermylen J: Thrombosis. Moscow: Meditsina 1986.
14. Landolfi R, Scabbia E, Accora F etal: Beta-thromboglobulin in patients with acute and chronic coronary artery disease Acta Cardiol 1982, 37: 325–332.
15. Zahavi J, Zahavi M: Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease Thromb Haemost 1985, 53: 105–109.
16. Hughes A, Daunt S, Vass G, Wickes J: In-vivo platelet activation following myocardial infarction and acute coronary ischemia Thromb Haemost 1982, 48: 133–135.
17. Gallino A, Haeberti A, Baur HR, Straub PW: Fibrin formation and platelet aggregation in patients with severe coronary artery disease; relationship with the degree of myocardial ischemia Circulation 1985, 72: 27–30.
18. Bolton AE, Ludlam CA, Moore S, Pepper DS, Cash JD: Three approaches to the radioimmunoassay of human beta-thromboglobulin Br J Haematol 1976, 32: 233–238.
19. Nora JJ: Identifying the child at risk for coronary disease as an adult: A strategy for prevention J Pediatr 1980, 97: 706–714.
20. Noble MIM, ed.: Thrombosis as a unitary hypothesis of cardiovascular risk J Cardiovasc Risk 1995, 2: 177–233.
21. Andreyenko GV, Belokon NA, Zabotina ON, Karabasova MA, Aingorn Yed: Characteristics of haemostasis, fibrinolysis and lipids in prematurely infarcted fathers and their children [abstract] Kardiologia 1986, 5: 17–22.
22. Sewdarsen M, Vythilingum S, Jialal I, Desai RK, Becker P: Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease Atherosclerosis 1990, 83: 111–117.
23. Bonithon-Kopp C, Scarabin P-Y, Bara L, Castanier M, Jacqson A, Roger M: Relationship between sex hormones and haemostatic factors in healthy middle-aged men Atherosclerosis 1988, 71: 71–76.
24. Pumphrey CW, Dawes J: Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction Am J Cardiol 1982, 50: 1258–1261.
25. Strobl-Jager E, Fitscha P, Kaliman J, Widhalm K, Sinzinger H: Platelet half-life comparison to other in-vivo platelet function parameters such as thromboxane A2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesion with and without hyperlipoproteinemia Vasa 1986, 15: 373–378.
26. Mihai K, Peto J, Koltay E, Makary A, Timar S: Balance of prostacyclin and thromboxane in children of parents with premature coronary arterial disease Int J Cardiol 1992, 35: 13–18.
27. Akimova EV: Prostacyclin and thromboxane A2 levels in children and adolescents with inherited predisposition to coronary heart disease: Family study Coronary Artery Dis 1994, 5: 761–765.
28. Akimova EV: Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without family history of coronary heart disease [abstract] Kardiologia 1992, 5: 41–43.
29. Alpert JS: Cardiovascular diseases JAMA 1985, 254: 2264–2267.
30. Pyorala K, Debacker G, Graham I, Poolewilson P, Wood D: Prevention of coronary heart disease in clinical practice - recommendation of the task force of the European Atherosclerosis Society and European Society of Hypertension Eur Heart J 1994, 15: 1300–1331.